(3R,8S)-Falcarindiol

(3R,8S)-Falcarindiol is an inhibitor of NOS and TNF-alpha and related targets used in studies of MAPK / ERK Signaling and JAK-STAT Signaling and related signaling programs. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and cytokine-responsive transcriptional signaling and immune regulation in cardiovascular, cell signaling, and immunology models.

By inhibiting NOS and TNF-alpha and related targets, (3R,8S)-Falcarindiol can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and cytokine-responsive transcriptional signaling and immune regulation. The immunomodulator annotation adds relevance to immune-cell activation, cytokine, and mediator assays, together with downstream-response mapping in the same experimental setting. In cardiovascular, cell signaling, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving NOS and TNF-alpha and related targets
• Pathway perturbation studies connected to MAPK / ERK Signaling and JAK-STAT Signaling and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Immune-cell activation, cytokine, and mediator assays

Overall, (3R,8S)-Falcarindiol is appropriate when a defined chemical perturbant is needed to connect NOS and TNF-alpha and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular, cell signaling, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.